Filters

RNF39 Antibody, Cy7 Conjugated

RNF39 Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, RNF39 Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenRNF39
SpecificityThis is a highly specific antibody against RNF39
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range180-230/420
Subcellular locationCytoplasm
SourceKLH conjugated synthetic peptide derived from human RNF39
Gene ID number80352
Swiss ProtQ9H2S5
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen backgroundMay play a role in prolonged long term-potentiation (LTP) maintenance
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms HZFw1 LIRF
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetRNF39 Conjugated
Short name Conjugated, RNF39 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, RNF39 (Antibody to)
Alternative techniqueantibodies
Identity 18064
Gene RNF39
Long gene name ring finger protein 39
Locus 6p22, 1
Discovery year 2003-04-25
GenBank acession AF238315
Entrez gene record 80352
Pubmed identfication 11130983 11716498
RefSeq identity NM_170769
Classification Ring finger proteins
Havana BLAST/BLAT OTTHUMG00000031288

Subscribe to our Newsletter